Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study
- 1 May 1993
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 44 (4) , 403-405
- https://doi.org/10.1007/bf00316483
Abstract
In a depressed patient, the addition of citalopram 40–60 mg per day to treatment with amitriptyline 75 mg per day had no effect on the plasma levels of amitriptyline and nortriptyline, but it led to clinical improvement without the appearance of adverse effects. This and similar findings in four other patients comedicated with citalopram and amitriptyline (2 patients), clomipramine or maprotiline suggest that citalopram differs from other selective serotonin reuptake inhibitors, such as fluvoxamine and fluoxetine, which have been shown to increase tricyclic antidepressant plasma levels.Keywords
This publication has 14 references indexed in Scilit:
- Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography—mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Inhibitors of imipramine metabolism by human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]British Journal of Clinical Pharmacology, 1991
- Fluoxetine‐Induced Tricyclic Toxicity: Extent and DurationThe Journal of Clinical Pharmacology, 1991
- CitalopramDrugs, 1991
- Fluvoxamine-tricyclic antidepressant interactionEuropean Journal of Clinical Pharmacology, 1991
- Elevated antidepressant plasma levels after addition of fluoxetineAmerican Journal of Psychiatry, 1989
- Serum Fluoxetine and Norfluoxetine Concentrations and Antidepressant ResponseTherapeutic Drug Monitoring, 1989
- Fluoxetine Induces Elevation of Desipramine Level and Exacerbation of Geriatric Nonpsychotic DepressionJournal of Clinical Psychopharmacology, 1988
- Amitriptyline Pharmacokinetics and Clinical Response: II. Metabolic Polymorphism Assessed by Hydroxylation of Debrisoquine and MephenytoinInternational Clinical Psychopharmacology, 1986